These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6226199)

  • 41. [Left ventricular remodeling and hypertension. Course with antihypertensive therapy].
    Ollivier JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():73-7. PubMed ID: 1838922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diastolic relaxation and left ventricular blood filling in patients with hypertension].
    Gurgenian SV; Nikogosian KG; Mikaelian ES; Grigorian TZ; Babaian AS
    Kardiologiia; 1988 Jan; 28(1):45-9. PubMed ID: 2965772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicardipine and cardiac hypertrophy: effects on left ventricular mass. Haemodynamics and mechanical performance in renovascular hypertensive rats.
    Grellet J; Bonoron-Adèle S; Stuyvers B; Tariosse L; Besse P
    Cardiovasc Res; 1991 Jun; 25(6):484-90. PubMed ID: 1832334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.
    Trimarco B; De Luca N; Rosiello G; Ricciardelli B; Betocchi S; Filardi PP; Raponi M; Condorelli M
    Am J Cardiol; 1989 Oct; 64(12):745-51. PubMed ID: 2572165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium sensitivity of isometric tension in intact papillary muscles and chemically skinned trabeculae in different models of hypertensive hypertrophy.
    Pedroni P; Perez GN; Mattiazzi A
    Cardiovasc Res; 1990 Jul; 24(7):584-90. PubMed ID: 2145071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Left ventricular hypertrophy in arterial hypertension].
    Garnier LF; François G; Lang M; Raynaud P; Brochier M
    Presse Med; 1988 Feb; 17(7):333-8. PubMed ID: 2966353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of left ventricular hypertrophy by drug treatment of hypertension.
    Schlant RC
    Chest; 1985 Sep; 88(3 Suppl):194S-196S, 198S. PubMed ID: 3161707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of cardiac hypertrophy in humans.
    Tarazi RC; Fouad FM
    Hypertension; 1984; 6(6 Pt 2):III140-6. PubMed ID: 6240447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
    Frohlich ED
    Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Regression of biochemical changes in heart muscle hypertrophy].
    Zähringer J
    Z Kardiol; 1985; 74 Suppl 7():119-26. PubMed ID: 2868582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of cardiac contractile response to beta-adrenergic stimulation in normal and two-kidney, one-clip hypertensive rats treated with nitrendipine.
    Taquini CM; Gómez Llambi H; Mazzadi A; Fontan M; Gallo A
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S175-8. PubMed ID: 1715476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regression of myocardial hypertrophy and influence of adrenergic system.
    Sen S; Tarazi RC
    Am J Physiol; 1983 Jan; 244(1):H97-101. PubMed ID: 6295190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanical and non-mechanical factors in hypertensive hypertrophy, their clinical roles.
    Sugishita Y; Iida K; Yukisada K
    Jpn Circ J; 1990 May; 54(5):568-74. PubMed ID: 2172581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk for cardiac involvement in essential hypertension.
    Zahka KG
    Cardiol Clin; 1986 Feb; 4(1):81-93. PubMed ID: 2939953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heart and vessel hypertrophy in hypertension: possibilities of regression.
    Cífková R; Niederle P; Romanovská L; Skibová J; Frídl P; Skalická H; Widimský J
    J Hypertens Suppl; 1987 Dec; 5(5):S407-10. PubMed ID: 2965227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.